ISPOR - R.N. van Veen

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

R.N. van Veen

Sep 3, 2026, 08:55 AM

First Name : R.N.

Last Name : van Veen

Degrees : MD, PhD

HTA20 HEALTH ECONOMIC EVALUATION MODEL FOR BREAST CANCER RISK MANAGEMENT THROUGH PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

Oct 1, 2026, 00:00

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now